Used primarily in the pharmaceutical industry, this compound is a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and other neuroactive drugs. It plays a crucial role in the development of medications targeting central nervous system disorders, such as depression, anxiety, and certain neurodegenerative conditions. Its structural properties make it suitable for binding to specific serotonin receptors, enhancing therapeutic efficacy. Additionally, it is utilized in research to study neurotransmitter pathways and receptor interactions, aiding in the discovery of novel treatments for mental health disorders. Its trifluoromethyl group contributes to improved metabolic stability and bioavailability in drug formulations.